Table 1

Basic characteristics

GroupFPHTLEVP value
n8093
Age, year65±1967±160.51
Male sex, (%)57 (71.3)60 (64.5)0.32
Height, cm163.0±9.1161.5±9.70.32
Body weight, kg60.3±13.157.9±12.50.22
Previous history of liver disease3 (3.7)3 (3.2)0.87
Serum creatinine level on admission, mg/dL0.87 (0.7, 1.1)0.86 (0.6, 1.1)0.48
Type of status epilepticus0.48
 Tonic clonic seizure57 (71.3)72 (77.4)
 Tonic seizure0 (0)1 (1.1)
 Repeated partial seizures10 (12.5)10 (10.8)
 Absence of seizures0 (0)1 (1.1)
 Complex partial seizure13 (16.3)9 (9.7)
Cause of status epilepticus0.37
 Idiopathic seizure19 (23.8)15 (16.1)
 Acute stroke6 (7.5)12 (12.9)
 Old stroke22 (27.5)31 (33.3)
 Acute trauma2 (2.5)2 (2.2)
 Old trauma5 (6.3)1 (1.1)
 Brain neoplasm11 (13.8)12 (12.9)
 Others15 (18.8)20 (21.5)
Seizure duration before treatment, min42.0 (21, 90)60 (30, 80)0.25
  • Others were causes other than those listed, which each physician was unable to categorise. Continuous variables with a normal distribution are expressed as the mean±SD and compared using the Student’s t-test. Non-parametric continuous variables are expressed as medians (IQRs) and compared using the Mann-Whitney U test. Categorical variables are expressed as n (%) and compared using the χ2 test.

  • FPHT, fosphenytoin; LEV, levetiracetam.